Çıkman, D. İ. Et Al. 2022. Coexpression of immune checkpoint receptors: do we need to reconsider immunotherapy of ovarian cancer?. International Molecular Immunology & Immunogenetics Congress V (MIMIC V) , (İzmir, Turkey), 53.

Çıkman, D. İ., Kökoğlu, A., Kayan, B. Ö., Esen, F., Demirkıran, F., Deniz, G., ... Çetin, E.(2022). Coexpression of immune checkpoint receptors: do we need to reconsider immunotherapy of ovarian cancer? . International Molecular Immunology & Immunogenetics Congress V (MIMIC V) (pp.53). İzmir, Turkey

Çıkman, Duygu Et Al. "Coexpression of immune checkpoint receptors: do we need to reconsider immunotherapy of ovarian cancer?," International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Turkey, 2022

Çıkman, Duygu İ. Et Al. "Coexpression of immune checkpoint receptors: do we need to reconsider immunotherapy of ovarian cancer?." International Molecular Immunology & Immunogenetics Congress V (MIMIC V) , İzmir, Turkey, pp.53, 2022

Çıkman, D. İ. Et Al. (2022) . "Coexpression of immune checkpoint receptors: do we need to reconsider immunotherapy of ovarian cancer?." International Molecular Immunology & Immunogenetics Congress V (MIMIC V) , İzmir, Turkey, p.53.

@conferencepaper{conferencepaper, author={Duygu İlke Çıkman Et Al. }, title={Coexpression of immune checkpoint receptors: do we need to reconsider immunotherapy of ovarian cancer?}, congress name={International Molecular Immunology & Immunogenetics Congress V (MIMIC V)}, city={İzmir}, country={Turkey}, year={2022}, pages={53} }